BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 28673608)

  • 1. Mitochondrial biology in cancer stem cells.
    Loureiro R; Mesquita KA; Magalhães-Novais S; Oliveira PJ; Vega-Naredo I
    Semin Cancer Biol; 2017 Dec; 47():18-28. PubMed ID: 28673608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and upcoming mitochondrial targets for cancer therapy.
    Kim HK; Noh YH; Nilius B; Ko KS; Rhee BD; Kim N; Han J
    Semin Cancer Biol; 2017 Dec; 47():154-167. PubMed ID: 28627410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria in cancer stem cells: a target for therapy.
    Loureiro R; Mesquita KA; Oliveira PJ; Vega-Naredo I
    Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):102-14. PubMed ID: 23360288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell metabolism: a potential target for cancer therapy.
    Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
    Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging role of lipid metabolism alterations in Cancer stem cells.
    Yi M; Li J; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Peng S; Li X; Xiong W; Li G; Xiang B
    J Exp Clin Cancer Res; 2018 Jun; 37(1):118. PubMed ID: 29907133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells.
    Gao C; Shen Y; Jin F; Miao Y; Qiu X
    PLoS One; 2016; 11(5):e0154576. PubMed ID: 27167619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
    Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
    Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cancer stem cell hypothesis: a guide to potential molecular targets.
    Allegra A; Alonci A; Penna G; Innao V; Gerace D; Rotondo F; Musolino C
    Cancer Invest; 2014 Nov; 32(9):470-95. PubMed ID: 25254602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
    De Luca A; Fiorillo M; Peiris-Pagès M; Ozsvari B; Smith DL; Sanchez-Alvarez R; Martinez-Outschoorn UE; Cappello AR; Pezzi V; Lisanti MP; Sotgia F
    Oncotarget; 2015 Jun; 6(17):14777-95. PubMed ID: 26087310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance.
    Payandeh Z; Pirpour Tazehkand A; Barati G; Pouremamali F; Kahroba H; Baradaran B; Samadi N
    Biochimie; 2020 Dec; 179():32-45. PubMed ID: 32946993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells.
    Oh J; Hlatky L; Jeong YS; Kim D
    Toxins (Basel); 2016 Jun; 8(7):. PubMed ID: 27376325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells, metabolism, and therapeutic significance.
    Yang M; Liu P; Huang P
    Tumour Biol; 2016 May; 37(5):5735-42. PubMed ID: 26864589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells: a metastasizing menace!
    Bandhavkar S
    Cancer Med; 2016 Apr; 5(4):649-55. PubMed ID: 26773710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.